Global Markets Direct's latest Pharmaceutical
and Healthcare disease pipeline guide Retinal
Vein Occlusion - Pipeline Review, H1 2018, provides an overview of the
Retinal Vein Occlusion (Ophthalmology) pipeline landscape.
Retinal vein
occlusion is a blockage in one of the veins returning blood flow from the
retina. The retina is where images are converted to nerve signals. The primary
symptom of retinal vein occlusion is a sudden painless change in vision.
Predisposing factors are atherosclerosis, macular edema, diabetes, high blood
pressure, high cholesterol and age.
Global
Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Retinal
Vein Occlusion - Pipeline Review, H1 2018, provides comprehensive information
on the therapeutics under development for Retinal Vein Occlusion
(Ophthalmology), complete with analysis by stage of development, drug target,
mechanism of action (MoA), route of administration (RoA) and molecule type. The
guide covers the descriptive pharmacological action of the therapeutics, its
complete research and development history and latest news and press releases.
The Retinal Vein Occlusion (Ophthalmology)
pipeline guide also reviews of key players involved in therapeutic development
for Retinal Vein Occlusion and features dormant and discontinued projects. The
guide covers therapeutics under Development by Companies /Universities
/Institutes, the molecules developed by Companies in Phase III, Phase II, Phase
I, Preclinical, Discovery and Unknown stages are 3, 4, 3, 11, 1 and 1
respectively.
Retinal Vein Occlusion (Ophthalmology) pipeline
guide helps in identifying and tracking emerging players in the market and
their portfolios, enhances decision making capabilities and helps to create
effective counter strategies to gain competitive advantage. The guide is built
using data and information sourced from Global Markets Direct's proprietary
databases, company/university websites, clinical trial registries, conferences,
SEC filings, investor presentations and featured press releases from
company/university sites and industry-specific third party sources.
Additionally, various dynamic tracking processes ensure that the most recent
developments are captured on a real time basis.
The pipeline
guide provides a snapshot of the global therapeutic landscape of Retinal Vein
Occlusion (Ophthalmology). The pipeline guide reviews pipeline therapeutics for
Retinal Vein Occlusion (Ophthalmology) by companies and universities/research
institutes based on information derived from company and industry-specific
sources. The pipeline guide covers pipeline products based on several stages of
development ranging from pre-registration till discovery and undisclosed stages.
The pipeline guide features descriptive drug profiles for the pipeline products
which comprise, product description, descriptive licensing and collaboration
details, R&D brief, MoA & other developmental activities.
The pipeline guide reviews key companies
involved in Retinal Vein Occlusion (Ophthalmology) therapeutics and enlists all
their major and minor projects. The pipeline guide evaluates Retinal Vein
Occlusion (Ophthalmology) therapeutics based on mechanism of action (MoA), drug
target, route of administration (RoA) and molecule type. The pipeline guide
encapsulates all the dormant and discontinued pipeline projects. The pipeline
guide reviews latest news related to pipeline therapeutics for Retinal Vein
Occlusion (Ophthalmology).
Procure
strategically important competitor information, analysis, and insights to
formulate effective R&D strategies. Recognize emerging players with
potentially strong product portfolio and create effective counter-strategies to
gain competitive advantage. Find and recognize significant and varied types of
therapeutics under development for Retinal Vein Occlusion (Ophthalmology).
Classify potential new clients or partners in the target demographic. Develop
tactical initiatives by understanding the focus areas of leading companies.
Plan mergers and acquisitions meritoriously
by identifying key players and it's most promising pipeline therapeutics.
Formulate corrective measures for pipeline projects by understanding Retinal
Vein Occlusion (Ophthalmology) pipeline depth and focus of Indication
therapeutics. Develop and design in-licensing and out-licensing strategies by
identifying prospective partners with the most attractive projects to enhance
and expand business potential and scope. Adjust the therapeutic portfolio by
recognizing discontinued projects and understand from the know-how what drove
them from pipeline.
For more information on the research report,
refer to below link:
Related Reports:
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249
